Cargando…
Dural MALT lymphoma with disseminated disease
Central nervous system (CNS) lymphoma involving the dura mater is very rare and histologically is usually a subtype of non-Hodgkin's lymphoma (NHL) termed mucosa-associated lymphoid tissue (MALT) lymphoma. We present a case of a 46-year old woman with dural MALT lymphoma that was found to also...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222263/ https://www.ncbi.nlm.nih.gov/pubmed/22184513 http://dx.doi.org/10.4081/hr.2010.e10 |
_version_ | 1782217193390342144 |
---|---|
author | Matmati, Kelly Matmati, Nabil Hannun, Yusuf A. Rumboldt, Zoran Patel, Sunil Lazarchick, John Stuart, Robert Giglio, Pierre |
author_facet | Matmati, Kelly Matmati, Nabil Hannun, Yusuf A. Rumboldt, Zoran Patel, Sunil Lazarchick, John Stuart, Robert Giglio, Pierre |
author_sort | Matmati, Kelly |
collection | PubMed |
description | Central nervous system (CNS) lymphoma involving the dura mater is very rare and histologically is usually a subtype of non-Hodgkin's lymphoma (NHL) termed mucosa-associated lymphoid tissue (MALT) lymphoma. We present a case of a 46-year old woman with dural MALT lymphoma that was found to also involve a lacrimal gland, inguinal lymph nodes, and bone marrow. Magnetic resonance imaging of the brain showed an extra-axial enhancing mass approximately 6 cm in maximum diameter along the right frontotemporal convexity. Histopathology of the resected dural mass showed MALT lymphoma expressing CD20, CD52, CD19, and CD38. Molecular studies of the B-cell receptor heavy chain demonstrated monoclonality at the involved sites. The patient was treated with four cycles of fludarabine, mitoxantrone, and rituximab with complete remission. She had recurrence in the subcutaneous tissue of the back at 12 months but has remained free of intracranial disease for 31 months. A review of the literature reveals 57 cases of dural MALT lymphoma. Only 4 had extra-CNS involvement at presentation, and only 3 had local recurrence of the dural tumor. Because of the indolent behavior of this tumor, the intracranial portion can be treated conservatively after resection with or without chemotherapy. Deferral of brain radiation can be considered with close clinical and neuroimaging follow up. |
format | Online Article Text |
id | pubmed-3222263 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | PAGEPress Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-32222632011-12-19 Dural MALT lymphoma with disseminated disease Matmati, Kelly Matmati, Nabil Hannun, Yusuf A. Rumboldt, Zoran Patel, Sunil Lazarchick, John Stuart, Robert Giglio, Pierre Hematol Rep Case Report Central nervous system (CNS) lymphoma involving the dura mater is very rare and histologically is usually a subtype of non-Hodgkin's lymphoma (NHL) termed mucosa-associated lymphoid tissue (MALT) lymphoma. We present a case of a 46-year old woman with dural MALT lymphoma that was found to also involve a lacrimal gland, inguinal lymph nodes, and bone marrow. Magnetic resonance imaging of the brain showed an extra-axial enhancing mass approximately 6 cm in maximum diameter along the right frontotemporal convexity. Histopathology of the resected dural mass showed MALT lymphoma expressing CD20, CD52, CD19, and CD38. Molecular studies of the B-cell receptor heavy chain demonstrated monoclonality at the involved sites. The patient was treated with four cycles of fludarabine, mitoxantrone, and rituximab with complete remission. She had recurrence in the subcutaneous tissue of the back at 12 months but has remained free of intracranial disease for 31 months. A review of the literature reveals 57 cases of dural MALT lymphoma. Only 4 had extra-CNS involvement at presentation, and only 3 had local recurrence of the dural tumor. Because of the indolent behavior of this tumor, the intracranial portion can be treated conservatively after resection with or without chemotherapy. Deferral of brain radiation can be considered with close clinical and neuroimaging follow up. PAGEPress Publications 2010-12-03 /pmc/articles/PMC3222263/ /pubmed/22184513 http://dx.doi.org/10.4081/hr.2010.e10 Text en ©Copyright K. Matmati et al., 2010 This work is licensed under a Creative Commons Attribution 3.0 License (by-nc 3.0). Licensee PAGEPress, Italy |
spellingShingle | Case Report Matmati, Kelly Matmati, Nabil Hannun, Yusuf A. Rumboldt, Zoran Patel, Sunil Lazarchick, John Stuart, Robert Giglio, Pierre Dural MALT lymphoma with disseminated disease |
title | Dural MALT lymphoma with disseminated disease |
title_full | Dural MALT lymphoma with disseminated disease |
title_fullStr | Dural MALT lymphoma with disseminated disease |
title_full_unstemmed | Dural MALT lymphoma with disseminated disease |
title_short | Dural MALT lymphoma with disseminated disease |
title_sort | dural malt lymphoma with disseminated disease |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222263/ https://www.ncbi.nlm.nih.gov/pubmed/22184513 http://dx.doi.org/10.4081/hr.2010.e10 |
work_keys_str_mv | AT matmatikelly duralmaltlymphomawithdisseminateddisease AT matmatinabil duralmaltlymphomawithdisseminateddisease AT hannunyusufa duralmaltlymphomawithdisseminateddisease AT rumboldtzoran duralmaltlymphomawithdisseminateddisease AT patelsunil duralmaltlymphomawithdisseminateddisease AT lazarchickjohn duralmaltlymphomawithdisseminateddisease AT stuartrobert duralmaltlymphomawithdisseminateddisease AT gigliopierre duralmaltlymphomawithdisseminateddisease |